Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 351–375 of 27,380 studies, newest first · page 15 of 1096.

September 2026 25

  1. 2026-09-25

    Patterns of modifiable lifestyle, behavioural and health-related risk factors and their associations with incident dementia in UK Biobank

    ⚠ Preprint — not yet peer-reviewed Prevention and risk medRxiv (preprint)

    Key finding: Over a median follow-up of 13 years, 5,304 participants developed dementia. +3 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-09-25

    Speech Timing Measures Are Not Interchangeable Across Elicitation Methods in Senior Living Residents

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology medRxiv (preprint)

    Key finding: Twelve senior living residents completed four 60-second tasks: category fluency, two picture descriptions, and a self-generated narrative. +4 more findings

    Scored 19 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-09-25

    What Do Sugar, Gila Monsters, and the Therapeutic Dance Have in Common With GLP-1RA, Stroke, and Dementia?

    ✓ Peer-reviewed Drug development Neurology Genetics

    Key finding: Mary Poppins famously asserted that "a spoonful of sugar helps the medicine go down," but this bon mot is likely wrong in almost every way.

  4. 2026-09-25

    Genetic Insights Into Protective Effects of GLP-1 Receptor Agonists on Stroke and Alzheimer Disease Across Ancestries

    ✓ Peer-reviewed Drug development Neurology Genetics

    Key finding: Glucagon-like peptide-1 receptor agonists (GLP-1RA), widely used for type 2 diabetes (T2D) and obesity, have demonstrated pleiotropic effects, including cardiovascular benefits, with mounting evidence also suggesting potential beneficial effects on brain health.

  5. 2026-09-25

    Sleep Health in Adults with Intellectual Disability: Recent Advances and Persistent Evidence Gaps

    ✓ Peer-reviewed Down syndrome and Alzheimer's Current Treatment Options in Neurology

    Key finding: Recent Findings Recent observational data in adults with Down syndrome indicate that obstructive sleep apnoea is associated with adverse cardiometabolic, mortality and Alzheimer disease outcomes. +1 more finding

  6. 2026-09-25

    Epilepsy Mechanisms in Down Syndrome: Genetic and Pathophysiological Perspectives Across the Lifespan

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of Clinical Medicine

    Key finding: Seizures are a frequent comorbidity in individuals with Down syndrome and can exert significant negative consequences on cognitive capacity and quality of life.

  7. 2026-09-24

    Dementia Language Models: a generalizable and controllable representation of cognitive impairment

    ⚠ Preprint — not yet peer-reviewed Mild cognitive impairment bioRxiv

    Key finding: We introduce Dementia Language Models (DeLMs) – generalizable and controllable representations of cognitive impairment through language – alongside an evaluation framework for establishing their validity and clinical grounding. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2026-09-24

    DNA Methylation Concordance Between Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Human Brain Tissue in Neurodegenerative Diseases

    ⚠ Preprint — not yet peer-reviewed Lewy body dementia Preprints.org

    Key finding: PCA suggested that the preservation method was a major driver of variation, with PC1 explaining 24.2–48.5% of the variance, while PC2 captured additional variation (6.7–14.3%). +3 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-09-24

    Micro- and nanoplastics alter electrophysiological brain patterns and reshape human neurodevelopmental trajectories

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms bioRxiv

    Key finding: Transcriptomic analyses revealed activation of senescence-associated secretory phenotype (SASP) pathways. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2026-09-24

    A Review of Alzheimer’s Pathophysiology, Diagnostic Methods, and Multimodal Techniques

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Preprints.org

    Key finding: There is a better chance for potential treatments to work in the preliminary stages as no significant neuronal damage has occurred in its initial stages, which is why early detection is critical.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  11. 2026-09-24

    Long-term voluntary exercise reveals limited translation of hippocampal molecular responses into neuroprotection in 5xFAD mice

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms bioRxiv

    Key finding: Together, these findings demonstrate that the 5xFAD brain retains modest molecular responsiveness to prolonged voluntary exercise but may be unable to mount a sufficiently robust or coordinated response to produce broad neuroprotective effects. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  12. 2026-09-24

    LSD-pipeline: Causal Inference of miRNA Network Effects in Alzheimer's Disease

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms bioRxiv

    Key finding: Several miRNAs with no significant direct association with AD showed significant effects when estimated through their target networks, while others significant in direct analysis were not supported at the network level, underscoring the value of network-level analysis. +1 more finding

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-09-24

    Reducing Neutrophil Sialic Acid Residues Alleviates Cerebral Hypoperfusion in Alzheimer’s Models

    ⚠ Preprint — not yet peer-reviewed Vascular contributions bioRxiv

    Key finding: Elevated terminal sialylation of neutrophil glycoproteins contributes to capillary stalling and cerebral hypoperfusion in AD.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  14. 2026-09-24

    Aging and Alcohol Withdrawal Escalate CNS Hyperexcitability Across the Lifespan

    ⚠ Preprint — not yet peer-reviewed Prevention and risk Research Square

    Key finding: Aging and alcohol significantly increased CNS hyperexcitability in an age, strain, and sex dependent manner, demonstrating alcohol exacerbates aging related CNS hyperexcitability.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  15. 2026-09-24

    When Insomnia Becomes an Economic Disease: Linking Phenotype, Comorbidity, Treatment, and Societal Cost—An Evidence-Based Narrative Review

    ⚠ Preprint — not yet peer-reviewed Risk factors Preprints.org

    Key finding: Insomnia disorder affects approximately 10–20% of adults and is usually chronic. +4 more findings

    Scored 47 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  16. 2026-09-24

    Remote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention Studies

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia (New York, N. Y.)

    Key finding: Despite this, remote measures demonstrated excellent reliability (ICCs > 0.90 after 10 sessions) and strong construct validity, with tasks loading onto memory, attention, and executive function domains. +4 more findings

  17. 2026-09-24

    White Matter Slow-4 fALFF as a Complementary Marker in the Multimodal Alzheimer’s Disease Biomarker Landscape

    ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv

    Key finding: WM fALFF was significantly associated with GFAP (partial RZ = 5.35%), amyloid PET (partial RZ = 2.17%), tau PET (partial RZ = 3.52%), executive function (partial RZ = 2.61%), and mPACC (partial RZ = 3.53%). +3 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-09-24

    Extracellular CIRP induces neurotoxic astrocytes via TREM-1 in Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv

    Key finding: We found that eCIRP levels were significantly elevated in the cerebrospinal fluid (CSF) and plasma of AD patients compared with age-matched non-AD subjects, as well as in hTau.P301S mice (a model of AD tauopathy) compared with wildtype control mice.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2026-09-24

    A pericyte-to-myofibroblast transition links APOE4 to cerebrovascular degeneration

    ✓ Peer-reviewed Vascular contributions Cell

    Key finding: The strongest genetic AD risk factor, apolipoprotein E4 (APOE4), is associated with cerebrovascular degeneration, including vascular amyloid deposition and fibrosis. +1 more finding

  20. 2026-09-24

    Study of Ancestry, Health, Environment, and Late-Life Neurodegeneration (SAHEL)

    ⚠ Preprint — not yet peer-reviewed How common it is medRxiv (preprint)

    Key finding: Planned analyses will integrate gut microbiota profiling, retinal imaging, and brain magnetic resonance imaging to investigate biological pathways and markers associated with healthy aging and cognitive outcomes.

    Scored 39 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  21. 2026-09-24

    Elevation in Plasma p-tau217 Concentrations Among Blood Donors: An Exploratory Cross-Sectional Study

    ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv (preprint)

    Key finding: Plasma p-tau217 concentrations were positively associated with plasma TNF- (Kendalls {tau} = 0.339; P < .001) and IL-6 (Kendalls {tau} = 0.310; P < .001) concentrations. +4 more findings

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  22. 2026-09-24

    Cognition in Cardiovascular Disease

    ✓ Peer-reviewed Treatments Current Neurology and Neuroscience Reports

    Key finding: Acute cerebrovascular events once dominated efforts to protect the brain from cardiovascular disease.

  23. 2026-09-24

    Neuroinflamación como diana terapéutica en la enfermedad de Alzheimer: avances clínicos y perspectivas futuras

    ✓ Peer-reviewed Genetics Ciencia Latina Revista Científica Multidisciplinar

    Key finding: También se documentó la participación de astrocitos, vías como NF-κB, MAPK, JAK/STAT e inflamasomas, así como interacciones entre neuroinflamación, tau y APOE. +4 more findings

  24. 2026-09-23

    Parkinson’s Disease Onset in Light of Acquired Irreversible Piezo2 Channelopathy

    ⚠ Preprint — not yet peer-reviewed How common it is Preprints.org

    Key finding: Not a single common initiating cause had been attributed to these neurodegenerative diseases due to their multifactorial disease background. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  25. 2026-09-23

    High-Dimensional Multi-Omic Mapping of Post-Mortem Human Brain Using Iterative Indirect Immunofluorescence Imaging on Xenium-Processed Tissues

    ⚠ Preprint — not yet peer-reviewed Digital health tools bioRxiv

    Key finding: Immunofluorescence staining of FFPE tissue following Xenium processing also preserves cellular morphology, allowing the morphological complexity of distinct cell types to be captured and quantitated, especially for glial cells with highly ramified processes. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →